BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity

Molecular Psychiatry

Volumn 17, Issue 1, 2012, Pages 22-35

  Rakofsky, J J ^a   Ressler, K J ^b   Dunlop, B W ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bipolar disorder; brain derived neurotrophic factor; post traumatic stress disorder

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LITHIUM; MESSENGER RNA; VALPROIC ACID;

ALLELE; AMINO ACID SUBSTITUTION; AMYGDALOID NUCLEUS; BIPOLAR DISORDER; BRAIN CORTEX; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; COMORBIDITY; DISEASE SEVERITY; EPIGENETICS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL PATIENT; NERVE CELL PLASTICITY; NEUROIMAGING; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; COMORBIDITY; HUMANS; METHIONINE; STRESS DISORDERS, POST-TRAUMATIC; VALINE;

EID: 84855354003     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.121     Document Type: Review

References (183)

1. Coryell W, Scheftner W, Keller M, Endicott J, Maser J, Klerman GL. The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993; 150: 720-727. (Pubitemid 23137676)
2. Tsuang MT, Woolson RF. Mortality in patients with schizophrenia, mania, depression and surgical conditions. A comparison with general population mortality. Br J Psychiatry 1977; 130: 162-166. (Pubitemid 8027852)
3. Dedert EA, Green KT, Calhoun PS, Yoash-Gantz R, Taber KH, Mumford MM et al. Association of trauma exposure with psychiatric morbidity in military veterans who have served since September 11, 2001. J Psychiatr Res 2009; 43: 830-836.
4. Desai RA, Dausey D, Rosenheck RA. Suicide among discharged psychiatric inpatients in the Department of Veterans Affairs. Mil Med 2008; 173: 721-728.
5. Quarantini LC, Miranda-Scippa A, Nery-Fernandes F, Andrade-Nascimento M, Galvao-de-Almeida A, Guimaraes JL et al. The impact of comorbid posttraumatic stress disorder on bipolar disorder patients. J Affect Disord 2010; 123: 71-76.
6. Meade CS, McDonald LJ, Graff FS, Fitzmaurice GM, Griffin ML, Weiss RD. A prospective study examining the effects of gender and sexual/physical abuse on mood outcomes in patients with co-occurring bipolar I and substance use disorders. Bipolar Disord 2009; 11: 425-433.
7. Assion HJ, Brune N, Schmidt N, Aubel T, Edel MA, Basilowski M et al. Trauma exposure and post-traumatic stress disorder in bipolar disorder. Soc Psychiatry Psychiatr Epidemiol 2009; 44: 1041-1049.
8. Thatcher JW, Marchand WR, Thatcher GW, Jacobs A, Jensen C. Clinical characteristics and health service use of veterans with comorbid bipolar disorder and PTSD. Psychiatr Serv 2007; 58: 703-707. (Pubitemid 46841895)
9. Brown GR, McBride L, Bauer MS, Williford WO. Impact of childhood abuse on the course of bipolar disorder: a replication study in US veterans. J Affect Disord 2005; 89: 57-67. (Pubitemid 41740833)
10. Goldberg JF, Garno JL. Development of posttraumatic stress disorder in adult bipolar patients with histories of severe childhood abuse. J Psychiatr Res 2005; 39: 595-601. (Pubitemid 41278626)
11. Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004; 161: 2222-2229. (Pubitemid 39587287)
12. McElroy SL, Altshuler LL, Suppes T, Keck Jr PE, Frye MA, Denicoff KD et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001; 158: 420-426. (Pubitemid 32205199)
13. Simon NM, Smoller JW, Fava M, Sachs G, Racette SR, Perlis R et al. Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. J Psychiatr Res 2003; 37: 187-192. (Pubitemid 36321746)
14. Feske U, Frank E, Mallinger AG, Houck PR, Fagiolini A, Shear MK et al. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry 2000; 157: 956-962. (Pubitemid 30412347)
15. Mueser KT, Goodman LB, Trumbetta SL, Rosenberg SD, Osher C, Vidaver R et al. Trauma and posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol 1998; 66: 493-499. (Pubitemid 28272952)
16. Kennedy BL, Dhaliwal N, Pedley L, Sahner C, Greenberg R, Manshadi MS. Post-traumatic stress disorder in subjects with schizophrenia and bipolar disorder. J Ky Med Assoc 2002; 100: 395-399.
17. Maguire C, McCusker CG, Meenagh C, Mulholland C, Shannon C. Effects of trauma on bipolar disorder: the mediational role of interpersonal difficulties and alcohol dependence. Bipolar Disord 2008; 10: 293-302. (Pubitemid 351637694)
18. Neria Y, Olfson M, Gameroff MJ, Wickramaratne P, Pilowsky D, Verdeli H et al. Trauma exposure and posttraumatic stress disorder among primary care patients with bipolar spectrum disorder. Bipolar Disord 2008; 10: 503-510. (Pubitemid 351619166)
19. Strawn JR, Adler CM, Fleck DE, Hanseman D, Maue DK, Bitter S et al. Post-traumatic stress symptoms and trauma exposure in youth with first episode bipolar disorder. Early Interv Psychiatry 2010; 4: 169-173.
20. Steinbuchel PH, Wilens TE, Adamson JJ, Sgambati S. Posttraumatic stress disorder and substance use disorder in adolescent bipolar disorder. Bipolar Disord 2009; 11: 198-204.
21. Romero S, Birmaher B, Axelson D, Goldstein T, Goldstein BI, Gill MK et al. Prevalence and correlates of physical and sexual abuse in children and adolescents with bipolar disorder. J Affect Disord 2009; 112: 144-150.
22. Dilsaver SC, Benazzi F, Akiskal HS, Akiskal KK. Post-traumatic stress disorder among adolescents with bipolar disorder and its relationship to suicidality. Bipolar Disord 2007; 9: 649-655. (Pubitemid 47365634)
23. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602. (Pubitemid 40973434)
24. Kilpatrick DG, Ruggiero KJ, Acierno R, Saunders BE, Resnick HS, Best CL. Violence and risk of PTSD, major depression, substance abuse/dependence, and comorbidity: results from the National Survey of Adolescents. J Consult Clin Psychol 2003; 71: 692-700. (Pubitemid 36897402)
25. Galbaud du Fort G, Newman SC, Bland RC. Psychiatric comorbidity and treatment seeking. Sources of selection bias in the study of clinical populations. J Nerv Ment Dis 1993; 181: 467-474. (Pubitemid 24259624)
26. Kessler RC, Rubinow DR, Holmes C, Abelson JM, Zhao S. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med 1997; 27: 1079-1089. (Pubitemid 27401831)
27. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007; 64: 543-552. (Pubitemid 46718287)
28. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52: 1048-1060.
29. Bleich A, Koslowsky M, Dolev A, Lerer B. Post-traumatic stress disorder and depression. An analysis of comorbidity. Br J Psychiatry 1997; 170: 479-482. (Pubitemid 27224548)
30. Zimmermann P, Bruckl T, Nocon A, Pfister H, Lieb R, Wittchen HU et al. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry 2009; 66: 1341-1352.
31. Rakofsky JJ, Levy ST, Dunlop BW. Conceptualizing treatment nonadherence in patients with bipolar disorder and PTSD. CNS Spectr; advance online publication, 15 January 2011 (e-pub ahead of print).
32. Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck Jr PE et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006; 163: 232-239. (Pubitemid 44480842)
33. Jovanovic T, Norrholm SD, Fennell JE, Keyes M, Fiallos AM, Myers KM et al. Posttraumatic stress disorder may be associated with impaired fear inhibition: relation to symptom severity. Psychiatry Res 2009; 167: 151-160.
34. Sierra-Mercado D, Padilla-Coreano N, Quirk GJ. Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 2011; 36: 529-538.
35. Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry 2007; 62: 446-454. (Pubitemid 47284021)
36. Milad MR, Quinn BT, Pitman RK, Orr SP, Fischl B, Rauch SL. Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. Proc Natl Acad Sci USA 2005; 102: 10706-10711. (Pubitemid 41061618)
37. Geuze E, Westenberg HG, Heinecke A, de Kloet CS, Goebel R, Vermetten E. Thinner prefrontal cortex in veterans with posttraumatic stress disorder. NeuroImage 2008; 41: 675-681.
38. Drevets WC, Savitz J, Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 2008; 13: 663-681.
39. Phillips ML, Ladouceur CD, Drevets WC. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry 2008; 13: 829, 833-857.
40. McDonald C, Bullmore ET, Sham PC, Chitnis X, Wickham H, Bramon E et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry 2004; 61: 974-984. (Pubitemid 39336530)
41. Haznedar MM, Roversi F, Pallanti S, Baldini-Rossi N, Schnur DB, Licalzi EM et al. Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses. Biol Psychiatry 2005; 57: 733-742. (Pubitemid 40487917)
42. Beyer JL, Taylor WD, MacFall JR, Kuchibhatla M, Payne ME, Provenzale JM et al. Cortical white matter microstructural abnormalities in bipolar disorder. Neuropsychopharmacology 2005; 30: 2225-2229. (Pubitemid 41643973)
43. Etkin A, Wager TD. Functional neuroimaging of anxiety: a metaanalysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 2007; 164: 1476-1488. (Pubitemid 350069724)
44. Bremner JD, Vermetten E, Schmahl C, Vaccarino V, Vythilingam M, Afzal N et al. Positron emission tomographic imaging of neural correlates of a fear acquisition and extinction paradigm in women with childhood sexual-abuse-related post-traumatic stress disorder. Psychol Med 2005; 35: 791-806. (Pubitemid 40873380)
45. Rubinsztein JS, Fletcher PC, Rogers RD, Ho LW, Aigbirhio FI, Paykel ES et al. Decision-making in mania: a PET study. Brain 2001; 124(Part 12): 2550-2563. (Pubitemid 33134942)
46. Malhi GS, Lagopoulos J, Sachdev PS, Ivanovski B, Shnier R. An emotional Stroop functional MRI study of euthymic bipolar disorder. Bipolar Disord 2005; 7(Suppl 5): 58-69. (Pubitemid 43013462)
47. Arseneault L, Cannon M, Fisher HL, Polanczyk G, Moffitt TE, Caspi A. Childhood trauma and children's emerging psychotic symptoms: a genetically sensitive longitudinal cohort study. Am J Psychiatry 2011; 168: 65-72.
48. Cutajar MC, Mullen PE, Ogloff JR, Thomas SD, Wells DL, Spataro J. Schizophrenia and other psychotic disorders in a cohort of sexually abused children. Arch Gen Psychiatry 2010; 67: 1114-1119.
49. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677-736. (Pubitemid 32695243)
50. Maisonpierre PC, Belluscio L, Friedman B, Alderson RF,Wiegand SJ, Furth ME et al. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 1990; 5: 501-509. (Pubitemid 20369586)
51. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T. Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 2007; 85: 525-535.
52. Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 1990; 9: 2459-2464.
53. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998; 37: 1553-1561. (Pubitemid 28550429)
54. Yamamoto H, Gurney ME. Human platelets contain brain-derived neurotrophic factor. J Neurosci 1990; 10: 3469-3478.
55. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 2000; 470: 113-117. (Pubitemid 30151080)
56. Karege F, Schwald M, CisseM. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002; 328: 261-264. (Pubitemid 34876661)
57. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005; 26: 115-123. (Pubitemid 39600596)
58. Begliuomini S, Lenzi E, Ninni F, Casarosa E, Merlini S, Pluchino N et al. Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol 2008; 197: 429-435. (Pubitemid 351696256)
59. Begliuomini S, Casarosa E, Pluchino N, Lenzi E, Centofanti M, Freschi L et al. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod 2007; 22: 995-1002.
60. Bazak N, Kozlovsky N, Kaplan Z, Matar M, Golan H, Zohar J et al. Pre-pubertal stress exposure affects adult behavioral response in association with changes in circulating corticosterone and brain-derived neurotrophic factor. Psychoneuroendocrinology 2009; 34: 844-858.
61. Roth TL, Lubin FD, Funk AJ, Sweatt JD. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 2009; 65: 760-769.
62. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006; 9: 519-525.
63. Duman RS, Monteggia LM. A neurotrophic model for stressrelated mood disorders. Biol Psychiatry 2006; 59: 1116-1127.
64. Mitoma M, Yoshimura R, Sugita A, Umene W, Hori H, Nakano H et al. Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress? Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 679-685. (Pubitemid 351312365)
65. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002; 71: 651-655. (Pubitemid 34970137)
66. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269. (Pubitemid 36144114)
67. Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 2004; 24: 4401-4411. (Pubitemid 38608151)
68. Elzinga BM, Molendijk ML, Oude Voshaar RC, Bus BA, Prickaerts J, Spinhoven P et al. The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val(66)Met. Psychopharmacology (Berl) 2010; 214: 319-328.
69. Cirulli F, Reif A, Herterich S, Lesch KP, Berry A, Francia N et al. A novel BDNF polymorphism affects plasma protein levels in interaction with early adversity in rhesus macaques. Psychoneuroendocrinology 2010; 36: 372-379.
70. Zafra F, Castren E, Thoenen H, Lindholm D. Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Sci USA 1991; 88: 10037-10041. (Pubitemid 21915770)
71. Castren E, Zafra F, Thoenen H, Lindholm D. Light regulates expression of brain-derived neurotrophic factor mRNA in rat visual cortex. Proc Natl Acad Sci USA 1992; 89: 9444-9448.
72. Neeper SA, Gomez-Pinilla F, Choi J, Cotman CW. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 1996; 726: 49-56. (Pubitemid 26292229)
73. McEwen BS. The neurobiology and neuroendocrinology of stress. Implications for post-traumatic stress disorder from a basic science perspective. Psychiatr Clin N Am 2002; 25: 469-494, ix. (Pubitemid 34761248)
74. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995; 15(Part 1): 1768-1777.
75. Kumamaru E, Numakawa T, Adachi N, Yagasaki Y, Izumi A, Niyaz M et al. Glucocorticoid prevents brain-derived neurotrophic factor-mediated maturation of synaptic function in developing hippocampal neurons through reduction in the activity of mitogen-activated protein kinase. Mol Endocrinol 2008; 22: 546-558. (Pubitemid 351397784)
76. Schaaf MJ, De Kloet ER, Vreugdenhil E. Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation. Stress 2000; 3: 201-208. (Pubitemid 30423178)
77. Rattiner LM, Davis M, French CT, Ressler KJ. Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci 2004; 24: 4796-4806. (Pubitemid 38668204)
78. Eisch AJ, Bolanos CA, de Wit J, Simonak RD, Pudiak CM, Barrot M et al. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 2003; 54: 994-1005. (Pubitemid 37415034)
79. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006; 311: 864-868. (Pubitemid 43228853)
80. Schaaf MJ, Workel JO, Lesscher HM, Vreugdenhil E, Oitzl MS, de Kloet ER. Correlation between hippocampal BDNF mRNA expression and memory performance in senescent rats. Brain Res 2001; 915: 227-233. (Pubitemid 32947038)
81. Hall J, Thomas KL, Everitt BJ. Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci 2000; 3: 533-535. (Pubitemid 30332069)
82. Soliman F, Glatt CE, Bath KG, Levita L, Jones RM, Pattwell SS et al. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 2010; 327: 863-866.
83. Yu H, Wang Y, Pattwell S, Jing D, Liu T, Zhang Y et al. Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory. J Neurosci 2009; 29: 4056-4064.
84. Heldt SA, Stanek L, Chhatwal JP, Ressler KJ. Hippocampusspecific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 2007; 12: 656-670. (Pubitemid 46998249)
85. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004; 24: 10099-10102. (Pubitemid 39492034)
86. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003; 23: 6690-6694. (Pubitemid 36951196)
87. Peters J, Dieppa-Perea LM, Melendez LM, Quirk GJ. Induction of fear extinction with hippocampal-infralimbic BDNF. Science 2010; 328: 1288-1290.
88. Andero R, Heldt SA, Ye K, Liu X, Armario A, Ressler KJ. Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am J Psychiatry 2011; 168: 163-172.
89. Bredy TW,Wu H, Crego C, Zellhoefer J, Sun YE, Barad M. Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 2007; 14: 268-276. (Pubitemid 46625629)
90. Mossner R, Daniel S, Albert D, Heils A, Okladnova O, Schmitt A et al. Serotonin transporter function is modulated by brainderived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 2000; 36: 197-202. (Pubitemid 30047011)
91. Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 2001; 411: 86-89. (Pubitemid 32428194)
92. Carvalho AL, Caldeira MV, Santos SD, Duarte CB. Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br J Pharmacol 2008; 153(Suppl 1): S310-S324. (Pubitemid 351340985)
93. Kline DD, Ogier M, Kunze DL, Katz DM. Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice. J Neurosci 2010; 30: 5303-5310.
94. Cirulli F, Berry A, Bonsignore LT, Capone F, D'Andrea I, Aloe L et al. Early life influences on emotional reactivity: evidence that social enrichment has greater effects than handling on anxietylike behaviors, neuroendocrine responses to stress and central BDNF levels. Neurosci Biobehav Rev 2010; 34: 808-820.
95. Tapia-Arancibia L, Rage F, Givalois L, Arancibia S. Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol 2004; 25: 77-107. (Pubitemid 39582717)
96. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 1999; 189: 865-870. (Pubitemid 29189691)
97. Donovan MJ, Miranda RC, Kraemer R, McCaffrey TA, Tessarollo L, Mahadeo D et al. Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 1995; 147: 309-324.
98. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65: 732-741.
99. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 2004; 9: 609-620, 544. (Pubitemid 38850441)
100. Dunham JS, Deakin JF, Miyajima F, Payton A, Toro CT. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. J Psychiatr Res 2009; 43: 1175-1184.
101. Lin PY. State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study. Neurosci Lett 2009; 466: 139-143.
102. Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Goncalves CA et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 2006; 398: 215-219. (Pubitemid 43673698)
103. de Oliveira GS, Cereser KM, Fernandes BS, Kauer-Sant'Anna M, Fries GR, Stertz L et al. Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 2009; 43: 1171-1174.
104. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-stage bipolar disorder. Int J Neuropsychopharmacol 2009; 12: 447-458.
105. Kauer-Sant'Anna M, Tramontina J, Andreazza AC, Cereser K, da Costa S, Santin A et al. Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. Bipolar Disord 2007; 9(Suppl 1): 128-135. (Pubitemid 47399255)
106. Frey BN, Andreazza AC, Cereser KM, Martins MR, Valvassori SS, Reus GZ et al. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 2006; 79: 281-286. (Pubitemid 43782552)
107. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. Chronic lithium treatment increases the expression of brainderived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 2001; 158: 100-106.
108. Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 2009; 14: 51-59.
109. Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W et al. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 2009; 14: 755-763.
110. Kohli MA, Salyakina D, Pfennig A, Lucae S, Horstmann S, Menke A et al. Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients. Arch Gen Psychiatry 2010; 67: 348-359.
111. Dell'osso L, Carmassi C, Del Debbio A, Dell'osso MC, Bianchi C, da Pozzo E et al. Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 899-902.
112. Hauck S, Kapczinski F, Roesler R, de Moura Silveira Jr E, Magalhaes PV, Kruel LR et al. Serum brain-derived neurotrophic factor in patients with trauma psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 459-462.
113. Bonne O, Gill J, Luckenbaugh D, Owens M, Alesci S, Neumeister A et al. Corticotropin-releasing factor, interleukin-6, brainderived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine. J Clin Psychiatry 2011; 72: 1124-1128.
114. Berger W, Mehra A, Lenoci M, Metzler TJ, Otte C, Tarasovsky G et al. Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 1279-1284.
115. Hosang GM, Uher R, Keers R, Cohen-Woods S, Craig I, Korszun A et al. Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. J Affect Disord 2010; 125: 345-349.
116. Kunugi H, Iijima Y, Tatsumi M, Yoshida M, Hashimoto R, Kato T et al. No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. Biol Psychiatry 2004; 56: 376-378. (Pubitemid 39164523)
117. Liu L, Foroud T, Xuei X, Berrettini W, Byerley W, Coryell Wet al. Evidence of association between brain-derived neurotrophic factor gene and bipolar disorder. Psychiatr Genet 2008; 18: 267-274.
118. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003; 48: 186-189.
119. Kim B, Kim CY, Hong JP, Kim SY, Lee C, Joo YH. Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the Met allele with suicidal behavior of bipolar patients. Neuropsychobiology 2008; 58: 97-103.
120. Skibinska M, Hauser J, Czerski PM, Leszczynska-Rodziewicz A, Kosmowska M, Kapelski P et al. Association analysis of brainderived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J Biol Psychiatry 2004; 5: 215-220. (Pubitemid 44121701)
121. Kremeyer B, Herzberg I, Garcia J, Kerr E, Duque C, Parra V et al. Transmission distortion of BDNF variants to bipolar disorder type I patients from a South American population isolate. Am J Med Genet B 2006; 141B: 435-439. (Pubitemid 44024435)
122. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 2002; 7: 579-593.
123. Vincze I, Perroud N, Buresi C, Baud P, Bellivier F, Etain B et al. Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disord 2008; 10: 580-587. (Pubitemid 352003826)
124. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook Jr EH. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004; 161: 1698-1700. (Pubitemid 39201469)
125. Strauss J, Barr CL, George CJ, Devlin B, Vetro A, Kiss E et al. Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: confirmation in a Hungarian sample. Mol Psychiatry 2005; 10: 861-867. (Pubitemid 43080120)
126. Muller DJ, de Luca V, Sicard T, King N, Strauss J, Kennedy JL. Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br J Psychiatry 2006; 189: 317-323. (Pubitemid 44606744)
127. Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH. Confirmation of association between the Val66-Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet B 2005; 139B: 51-53. (Pubitemid 41552298)
128. Cichon S, Schumacher J, Abou Jamra R, Becker T, Ohlraun S, Klopp N et al. Supportive evidence for a relationship between genetic variations at the brain-derived neurotrophic factor (BDNF) locus and depressive symptoms in affective disorder and schizophrenia. Am J Med Genet B 2004; 130: 27.
129. Green EK, Raybould R, Macgregor S, Hyde S, Young AH, O'Donovan MC et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br J Psychiatry 2006; 188: 21-25. (Pubitemid 43021922)
130. Tang J, Xiao L, Shu C,Wang G, Liu Z,Wang X et al. Association of the brain-derived neurotrophic factor gene and bipolar disorder with early age of onset in mainland China. Neurosci Lett 2008; 433: 98-102.
131. Oswald P, Del-Favero J, Massat I, Souery D, Claes S, Van Broeckhoven C et al. Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study. Am J Med Genet B 2004; 129B: 34-35. (Pubitemid 38989064)
132. Nakata K, Ujike H, Sakai A, Uchida N, Nomura A, Imamura T et al. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 2003; 337: 17-20. (Pubitemid 36078301)
133. Strauss J, Barr CL, George CJ, King N, Shaikh S, Devlin B et al. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am J Med Genet B 2004; 131B: 16-19. (Pubitemid 39458432)
134. Xu J, Liu Y, Wang P, Li S, Wang Y, Li J et al. Positive association between the brain-derived neurotrophic factor (BDNF) gene and bipolar disorder in the Han Chinese population. Am J Med Genet B 2010; 153B: 275-279.
135. Savitz J, van der Merwe L, Ramesar R. Personality endophenotypes for bipolar affective disorder: a family-based genetic association analysis. Genes Brain Behav 2008; 7: 869-876.
136. Kesebir S, Vahip S, Akdeniz F, Yuncu Z, Alkan M, Akiskal H. Affective temperaments as measured by TEMPS-A in patients with bipolar I disorder and their first-degree relatives: a controlled study. J Affect Disord 2005; 85: 127-133. (Pubitemid 40386533)
137. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000; 59(Suppl 1): S5-S30. (Pubitemid 32164448)
138. Rybakowski JK, Suwalska A, Skibinska M, Szczepankiewicz A, Leszczynska-Rodziewicz A, Permoda A et al. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry 2005; 38: 166-170. (Pubitemid 41059223)
139. Mandelli L, Mazza M, Martinotti G, Tavian D, Colombo E, Missaglia S et al. Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance. J Psychopharmacol 2010; 24: 1747-1754.
140. Rybakowski JK, Borkowska A, Czerski PM, Skibinska M, Hauser J. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 2003; 5: 468-472. (Pubitemid 38072252)
141. Rybakowski JK, Borkowska A, Skibinska M, Hauser J. Illnessspecific association of val66met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Mol Psychiatry 2006; 11: 122-124. (Pubitemid 43164612)
142. Savitz J, van der Merwe L, Stein DJ, Solms M, Ramesar R. Genotype and childhood sexual trauma moderate neurocognitive performance: a possible role for brain-derived neurotrophic factor and apolipoprotein E variants. Biol Psychiatry 2007; 62: 391-399. (Pubitemid 47284025)
143. Matsuo K, Walss-Bass C, Nery FG, Nicoletti MA, Hatch JP, Frey BN et al. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmacology 2009; 34: 1904-1913.
144. Chepenik LG, Fredericks C, Papademetris X, Spencer L, Lacadie C, Wang F et al. Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology 2009; 34: 944-951.
145. McIntosh AM, Moorhead TW, McKirdy J, Sussmann JE, Hall J, Johnstone EC et al. Temporal grey matter reductions in bipolar disorder are associated with the BDNF Val66Met polymorphism. Mol Psychiatry 2007; 12: 902-903. (Pubitemid 47482703)
146. Frey BN, Stanley JA, Nery FG, Monkul ES, Nicoletti MA, Chen HH et al. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study. Bipolar Disord 2007; 9(Suppl 1): 119-127. (Pubitemid 47399254)
147. Okada T, Hashimoto R, Numakawa T, Iijima Y, Kosuga A, Tatsumi M et al. A complex polymorphic region in the brainderived neurotrophic factor (BDNF) gene confers susceptibility to bipolar disorder and affects transcriptional activity. Mol Psychiatry 2006; 11: 695-703. (Pubitemid 43989816)
148. Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS et al. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B 2006; 141B: 387-393. (Pubitemid 43872891)
149. Lee H, Kang R, Lim S, Paik J, Choi M, Lee M. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and post-traumatic stress disorder. Stress Health 2006; 22: 115-119. (Pubitemid 43670643)
150. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006; 314: 140-143. (Pubitemid 44547760)
151. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF et al. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 2005; 30: 1353-1361. (Pubitemid 40848089)
152. Montag C, Basten U, Stelzel C, Fiebach CJ, Reuter M. The BDNF Val66Met polymorphism and anxiety: support for animal knockin studies from a genetic association study in humans. Psychiatry Res 2010; 179: 86-90.
153. McFarlane AC. The aetiology of post-traumatic morbidity: predisposing, precipitating and perpetuating factors. Br J Psychiatry 1989; 154: 221-228. (Pubitemid 19050164)
154. Frustaci A, Pozzi G, Gianfagna F, Manzoli L, Boccia S. Metaanalysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 2008; 58: 163-170.
155. Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 2009; 14: 681-695.
156. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007; 8: 355-367. (Pubitemid 46652469)
157. Lavebratt C, Aberg E, Sjoholm LK, Forsell Y. Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. J Affect Disord 2010; 125: 249-255.
158. Gleeson JF, Rawlings D, Jackson HJ, McGorry PD. Agreeableness and neuroticism as predictors of relapse after first-episode psychosis: a prospective follow-up study. J Nerv Ment Dis 2005; 193: 160-169. (Pubitemid 40357704)
159. Rubin DC, Berntsen D, Bohni MK. A memory-based model of posttraumatic stress disorder: evaluating basic assumptions underlying the PTSD diagnosis. Psychol Rev 2008; 115: 985-1011.
160. Elzinga BM, Bremner JD. Are the neural substrates of memory the final common pathway in posttraumatic stress disorder (PTSD)? J Affect Disord 2002; 70: 1-17. (Pubitemid 34756608)
161. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531. (Pubitemid 26403928)
162. Vythilingam M, Luckenbaugh DA, Lam T, Morgan III CA, Lipschitz D, Charney DS et al. Smaller head of the hippocampus in Gulf War-related posttraumatic stress disorder. Psychiatry Res 2005; 139: 89-99. (Pubitemid 40910181)
163. Woodward SH, Kaloupek DG, Streeter CC, Martinez C, Schaer M, Eliez S. Decreased anterior cingulate volume in combat-related PTSD. Biol Psychiatry 2006; 59: 582-587. (Pubitemid 43357951)
164. Gorrindo T, Blair RJ, Budhani S, Dickstein DP, Pine DS, Leibenluft E. Deficits on a probabilistic response-reversal task in patients with pediatric bipolar disorder. Am J Psychiatry 2005; 162: 1975-1977. (Pubitemid 41428633)
165. McKirdy J, Sussmann JE, Hall J, Lawrie SM, Johnstone EC, McIntosh AM. Set shifting and reversal learning in patients with bipolar disorder or schizophrenia. Psychol Med 2009; 39: 1289-1293.
166. Rybakowski JK, Twardowska K. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. J Psychiatr Res 1999; 33: 363-370. (Pubitemid 29392684)
167. Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 2004; 184: 496-502. (Pubitemid 38725709)
168. Yehuda R, Flory JD, Pratchett LC, Buxbaum J, Ising M, Holsboer F. Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD. Psychopharmacology (Berl) 2010; 212: 405-417.
169. Cougle JR, Timpano KR, Sachs-Ericsson N, Keough ME, Riccardi CJ. Examining the unique relationships between anxiety disorders and childhood physical and sexual abuse in the National Comorbidity Survey-Replication. Psychiatry Res 2010; 177: 150-155.
170. Garakani A, Mathew SJ, Charney DS. Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J Med 2006; 73: 941-949. (Pubitemid 46040391)
171. Weiss EL, Longhurst JG, Mazure CM. Childhood sexual abuse as a risk factor for depression in women: psychosocial and neurobiological correlates. Am J Psychiatry 1999; 156: 816-828. (Pubitemid 29260334)
172. Institute of Medicine (IOM). Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence. The National Academies Press: Washington, DC, 2008.
173. Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev 2006; CD002795.
174. Jovanovic T, Ressler KJ. How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD. Am J Psychiatry 2010; 167: 648-662.
175. Frielingsdorf H, Bath KG, Soliman F, Difede J, Casey BJ, Lee FS. Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder. Ann N Y Acad Sci 2010; 1208: 150-157.
176. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004; 61: 1136-1144. (Pubitemid 39463415)
177. Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K et al. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry 2006; 63: 298-304. (Pubitemid 43345354)
178. Guastella AJ, Richardson R, Lovibond PF, Rapee RM, Gaston JE, Mitchell P et al. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry 2008; 63: 544-549.
179. Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA et al. Efficacy of D-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry 2010; 67: 365-370.
180. Kushner MG, Kim SW, Donahue C, Thuras P, Adson D, Kotlyar M et al. Cycloserine augmented exposure therapy for obsessivecompulsive disorder. Biol Psychiatry 2007; 62: 835-838. (Pubitemid 47488217)
181. Wilhelm S, Buhlmann U, Tolin DF, Meunier SA, Pearlson GD, Reese HE et al. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry 2008; 165: 335-341; quiz 409. (Pubitemid 351704489)
182. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000; 57: 481-489. (Pubitemid 30257262)
183. Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55. patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990; 147: 431-434. (Pubitemid 20107105)